The association of hepatic steatosis and fibrosis with heart failure and mortality
Cardiovascular Diabetology Oct 02, 2021
Park J, Kim G, Kim H, et al. - Findings revealed that hepatic steatosis and/or advanced fibrosis as evaluated via fatty liver index (FLI) and BARD score was significantly related to the risk of heart failure (HF) and mortality.
This study included 778,739 people without HF and 7,445 patients with pre-existing HF aged 40 to 80 years who participated in a national health check-up.
Applying cutoff values for FLI and BARD score, presence of hepatic steatosis and advanced hepatic fibrosis was ascertained.
An FLI ≥ 60 was associated with elevated risk for incident heart failure (iHF) (hazard ratio [HR], 1.30), hospitalized HF (hHF) (HR 1.54), all-cause death (HR 1.62), and cardiovascular (CV) death (HR 1.41) in the general population and hHF (HR 1.26) and all-cause death (HR 1.54) in the HF patient group, vs an FLI < 20.
In nonalcoholic fatty liver disease cases, advanced liver fibrosis was related to elevated risk for iHF, hHF, and all-cause death in the general population and all-cause mortality and CV mortality in the HF patient group.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries